Jacobs Levy Equity Management, Inc Chimerix Inc Transaction History

Jacobs Levy Equity Management, Inc

$23.2 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.9 - $1.06 $195,444 - $230,189	217,160 Added 99.02%	436,460 $419,000
Q3 2023 Nov 16, 2023	SELL	$0.94 - $1.23 $949,897 - $1.24 Million	-1,010,529 Reduced 82.17%	219,300 $210,000
Q2 2023 Aug 14, 2023	BUY	$1.1 - $1.54 $689,136 - $964,791	626,488 Added 103.84%	1,229,829 $1.49 Million
Q1 2023 May 15, 2023	SELL	$1.19 - $2.09 $1.09 Million - $1.91 Million	-914,883 Reduced 60.26%	603,341 $760,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.35 $2.32 Million - $3.26 Million	1,387,961 Added 1065.51%	1,518,224 $2.82 Million
Q3 2022 Nov 15, 2022	BUY	$1.81 - $2.76 $235,776 - $359,525	130,263 New	130,263 $251,000
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $152,545 - $224,708	-25,681 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $11,061 - $14,361	1,467 Added 6.06%	25,681 $205,000
Q1 2021 May 17, 2021	SELL	$4.76 - $11.25 $2.05 Million - $4.85 Million	-431,451 Reduced 94.69%	24,214 $233,000
Q4 2020 Feb 16, 2021	SELL	$2.43 - $5.42 $77,086 - $171,938	-31,723 Reduced 6.51%	455,665 $2.2 Million
Q3 2020 Nov 16, 2020	SELL	$2.3 - $3.72 $784 - $1,268	-341 Reduced 0.07%	487,388 $1.21 Million
Q2 2020 Aug 17, 2020	BUY	$1.33 - $3.63 $631,495 - $1.72 Million	474,809 Added 3674.99%	487,729 $1.51 Million
Q1 2020 May 15, 2020	SELL	$1.27 - $2.33 $715,921 - $1.31 Million	-563,718 Reduced 97.76%	12,920 $19,000
Q4 2019 Feb 14, 2020	BUY	$1.3 - $2.72 $148,375 - $310,447	114,135 Added 24.68%	576,638 $1.17 Million
Q3 2019 Nov 14, 2019	BUY	$1.93 - $4.21 $487,919 - $1.06 Million	252,808 Added 120.56%	462,503 $1.09 Million
Q2 2019 Aug 13, 2019	BUY	$2.05 - $4.32 $272,051 - $573,298	132,708 Added 172.38%	209,695 $906,000
Q1 2019 May 14, 2019	SELL	$1.79 - $3.12 $309,333 - $539,173	-172,812 Reduced 69.18%	76,987 $162,000
Q4 2018 Feb 14, 2019	SELL	$2.24 - $3.9 $37,636 - $65,527	-16,802 Reduced 6.3%	249,799 $642,000
Q3 2018 Nov 14, 2018	BUY	$3.58 - $4.9 $70,472 - $96,456	19,685 Added 7.97%	266,601 $1.04 Million
Q2 2018 Aug 14, 2018	SELL	$4.43 - $5.14 $120,402 - $139,700	-27,179 Reduced 9.92%	246,916 $1.18 Million
Q1 2018 May 15, 2018	BUY	$4.65 - $5.9 $327,360 - $415,360	70,400 Added 34.56%	274,095 $1.43 Million
Q4 2017 Feb 13, 2018	BUY	$4.32 - $5.52 $212,919 - $272,064	49,287 Added 31.92%	203,695 $943,000
Q3 2017 Nov 14, 2017	BUY	$4.35 - $5.25 $386,401 - $466,347	88,828 Added 135.45%	154,408 $811,000
Q2 2017 Nov 09, 2017	BUY	N/A	65,580	65,580 $357,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$8.54 Million
0.12% of portfolio
Monaco Asset Management Sam

4.38M
Shares

$4.25 Million
0.63% of portfolio
Vanguard Group Inc Valley Forge, PA

4.35M
Shares

$4.22 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.22M
Shares

$2.16 Million
0.03% of portfolio
Acadian Asset Management LLC Boston, MA

2.17M
Shares

$2.11 Million
0.01% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account